ReviewFrontiers in toxicology2026
Micro- and nanoplastic exposure as an emerging risk factor for depressive-like phenotypes across species: a systematic review.
Review in Frontiers in toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The pervasive environmental presence of micro- and nanoplastics (MNPs), combined with their ability to cross biological barriers and accumulate in the brain, has raised significant concerns regarding their neurotoxic potential. While neuroinflammatory and neurodegenerative effects are increasingly documented, a focused synthesis of their impact on depression-relevant behaviors is lacking. This systematic review evaluates the evidence linking MNPs exposure to depressive-like phenotypes across species. Following PRISMA guidelines, nine animal studies and one human cross-sectional study met the inclusion criteria. Rodent models exposed to MNPs, primarily polystyrene, showed consistent induction of depressive-like behaviors, whereas aquatic models exhibited neurobehavioral alterations compatible with depression-relevant phenotypes. Effects were dose-dependent and influenced by particle characteristics, exposure window, and sex. Preliminary human data suggest a positive association between estimated environmental MNPs exposure and depressive symptoms. Although evidence remains limited and methodologically heterogeneous, converging findings across experimental models indicate that MNPs exposure may represent a potential emerging risk factor for depression-related outcomes, possibly mediated by neuroinflammatory processes and neuronal damage. Future research requires standardized behavioral assessments, environmentally relevant exposure models, and longitudinal human studies with direct exposure biomonitoring to establish causality and public health relevance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.